Dacrioadenite bilateral causada pelo vírus Epstein-Barr: relato de caso

Moscovici, Bernardo Kaplan; Romero, Ivana Lopes; Filho, José Vital; Bison, Simone Haber Duellberg Von Faber

doi:10.1590/s0004-27492009000600017

Cited by 4 publications

(6 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 In our case, the patient worsened over months even after corticosteroid treatment. Previous reports by Rhem, 1 Aburn, 2 Marchese-Ragona, 3 and Moscovici 4 have not attributed EBV to be resistant to corticosteroids; in fact, patients experienced rapid improvement or resolution within 3 days to 3 weeks of starting treatment. This condition is usually highly sensitive to corticosteroid treatment and the classic response may be considered clinically diagnostic.…”

Section: Discussionmentioning

confidence: 89%

“…To the authors' knowledge, while there has been computed tomography (CT) images presented, 1,2,4,8,11 no prior study has published MRI images demonstrating biopsy-proven EBV dacryoadenitis. On imaging, dacryoadenitis from infectious or in ammatory etiologies commonly present as hyperenhancement of the lacrimal gland affecting the orbital and palpebral lobes without bony changes.…”

Section: Discussionmentioning

confidence: 99%

“…2,3 Patients with systemic EBV infections, such as infectious mononucleosis, have also been noted to have a range of ocular manifestations, including dacryoadenitis. 4,5 Because of the self-limiting nature of viral dacryoadenitis, patients often experience resolution of their symptoms with symptomatic treatment and do not need to undergo further evaluation.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Atypical presentation of bilateral Epstein-Barr virus dacryoadenitis: A case report of corticosteroid resistant orbital inflammation

Sweeney

Tan

Tauchi-Nishi

2022

Preprint

View full text Add to dashboard Cite

Epstein-Barr virus is a known cause of dacryoadenitis that is typically sensitive to corticosteroid treatment. When affecting the orbit, particularly the lacrimal gland, Epstein-Barr virus may cause chronic proptosis and a bilateral lacrimal mass effect. We provide a case of bilateral Epstein-Barr virus associated dacryoadenitis initially resistant to corticosteroid treatment requiring biopsy and confirmation by polymerase chain reaction of lacrimal tissue. Herein, we discuss the presentation with associated magnetic resonance imaging and histopathologic images, diagnostic dilemma, and treatment of an atypical case.

show abstract

Section: Discussionmentioning

confidence: 89%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Atypical presentation of bilateral Epstein-Barr virus dacryoadenitis: A case report of corticosteroid resistant orbital inflammation

Sweeney

Tan

Tauchi-Nishi

2022

Preprint

View full text Add to dashboard Cite

show abstract

“…In our case, the patient worsened over months even after corticosteroid treatment. Previous reports by Rhem [ 1 ], Aburn [ 2 ], Marchese-Ragona [ 3 ], and Moscovici [ 4 ] have not attributed EBV to be resistant to corticosteroids; in fact, patients experienced rapid improvement or resolution within 3 days to 3 weeks of starting treatment. This condition is usually highly sensitive to corticosteroid treatment and the classic response may be considered clinically diagnostic.…”

Section: Discussionmentioning

confidence: 99%

“…Several reports have described dacryoadenitis as one of the only clinical signs of an Epstein-Barr virus (EBV) infection [ 2 , 3 ]. Patients with systemic EBV infections, such as infectious mononucleosis, have also been noted to have a range of ocular manifestations, including dacryoadenitis [ 4 , 5 ]. Because of the self-limiting nature of viral dacryoadenitis, patients often experience resolution of their symptoms with symptomatic treatment and do not need to undergo further evaluation.…”

Section: Introductionmentioning

confidence: 99%